527 related articles for article (PubMed ID: 28648665)
21. Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1.
Xie Y; Deng H; Wei R; Sun W; Qi Y; Yao S; Cai L; Wang Y; Deng Z
Int J Biol Macromol; 2019 Jul; 133():137-147. PubMed ID: 30954590
[TBL] [Abstract][Full Text] [Related]
22. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Yan H; Zhang B; Fang C; Chen L
Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
[TBL] [Abstract][Full Text] [Related]
23. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
Li Y; Liu J; Liu ZZ; Wei WB
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
[TBL] [Abstract][Full Text] [Related]
25. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; D'Anneo A; Carlisi D; De Blasio A; Giuliano M; Tesoriere G; Giordano A; Vento R
Int J Oncol; 2014 Nov; 45(5):2013-23. PubMed ID: 25174983
[TBL] [Abstract][Full Text] [Related]
27. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
[TBL] [Abstract][Full Text] [Related]
28. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
Lu J; Song G; Tang Q; Yin J; Zou C; Zhao Z; Xie X; Xu H; Huang G; Wang J; Lee DF; Khokha R; Yang H; Shen J
Oncogene; 2017 Jan; 36(2):231-241. PubMed ID: 27270422
[TBL] [Abstract][Full Text] [Related]
29. Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262.
Song K; Liu N; Yang Y; Qiu X
Tumour Biol; 2016 May; 37(5):6493-9. PubMed ID: 26634745
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
Wang Y; Zhang S; Xu Y; Zhang Y; Guan H; Li X; Li Y; Wang Y
Tumour Biol; 2016 Nov; 37(11):15211-15220. PubMed ID: 27683056
[TBL] [Abstract][Full Text] [Related]
31. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
32. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
Wang W; Zhou X; Wei M
Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
[TBL] [Abstract][Full Text] [Related]
34. Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
Bao Y; Peng L; Ma J; Liu K; Li W
Genet Mol Res; 2015 Dec; 14(4):16771-81. PubMed ID: 26681023
[TBL] [Abstract][Full Text] [Related]
35. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
36. MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.
Liu Y; Zhu ST; Wang X; Deng J; Li WH; Zhang P; Liu BS
Technol Cancer Res Treat; 2016 Oct; 15(5):NP40-8. PubMed ID: 26306402
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells.
Liu M; Xiusheng H; Xiao X; Wang Y
Oncol Rep; 2016 Dec; 36(6):3371-3378. PubMed ID: 27779704
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA‑944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma.
Yan T; Zhu S; Zhang J; Lu G; Lv C; Wei Y; Luo M
Mol Med Rep; 2018 Dec; 18(6):5221-5228. PubMed ID: 30280196
[TBL] [Abstract][Full Text] [Related]
39. MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma.
Liu S; Feng P
Cell Physiol Biochem; 2015; 37(5):1956-66. PubMed ID: 26584294
[TBL] [Abstract][Full Text] [Related]
40. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
